SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Placing result

16 Jun 2010 12:33

RNS Number : 7208N
Coal of Africa Limited
16 June 2010
 



Wednesday 16 June 2010

THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL

 

COAL OF AFRICA LIMITED ("CoAL" or the "Company")

 

Result of Placing

 

 

Further to the announcement earlier today, CoAL is pleased to announce that 50 million new ordinary shares in the Company (the "Placing Shares") have been successfully placed by J.P. Morgan Securities Ltd., which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), Macquarie First South Advisers (Proprietary) Limited ("Macquarie"), Evolution Securities Limited ("Evolution"), and Mirabaud Securities LLP ("Mirabaud") as Managers, and Renaissance Capital Limited ("Renaissance") as Institutional Selling Agent, to institutional and other investors.

 

The placing price has been set at 110 pence per share (or 12.38 South African Rand, or 1.88 Australian Dollar). The placing price is equivalent to a 0.2% discount to the closing mid-market price on the AIM market of the London Stock Exchange ("AIM") on 15 June 2010. Accordingly, the Placing will raise gross proceeds of approximately £55 million (approximately South African Rand 619 million/ Australian Dollar 94 million). The Placing Shares represent approximately 10.4% of CoAL's issued share capital prior to the Placing.

 

The Placing Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of CoAL including the right to receive all dividends and other distributions declared, made or paid after the date of issue.

 

The Company has applied for admission of the Placing Shares to trading on AIM and the Main Board of JSE Limited ("JSE"), and application will be made to the Australian Securities Exchange ("ASX"). It is expected that admission to trading on AIM and the main board of the Johannesburg Stock Exchange will take place on 21 June 2010 and listing on the Australian Stock Exchange take place on 22 June 2010.

 

Contacts

 

CoAL

Simon Farrell

Blair Sergeant

 

Tel: +61 (0) 417 985 383

Tel: +27 (0) 11 785 4518

J.P. Morgan Cazenove

Verne Grinstead

Neil Passmore

Tel: +44 (0) 20 7588 2828

Macquarie

Murray Stewart

Melanie de Nysschen

Tel: +27 (0) 11 583 2000

Evolution

Simon Edwards

Chris Sim

 

Tel: +44 (0) 20 7071 4300

Renaissance

John Porter

Simon Matthews

 

 

Tel:+44 (0) 20 7367-7777

Conduit PR

Jos Simson

Leesa Peters

Tel: +44 (0) 20 7429 6603

 

 

This Announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by J.P. Morgan Cazenove, Macquarie, Evolution, Mirabaud or Renaissance or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

J.P. Morgan Cazenove is acting as Global Co-ordinator and Sole Bookrunner, Macquarie is acting as joint lead manager, Evolution and Mirabaud Securities LLP are acting as co-lead managers in connection with the Placing. Renaissance is also acting for the Company as Institutional Selling Agent. J.P. Morgan Cazenove, Evolution, Mirabaud and Renaissance, which are authorised and regulated by the Financial Services Authority and Macquarie which are authorised and regulated by the Financial Services Board in South Africa, are acting for the Company in connection with the Placing and no-one else and none of J.P. Morgan Cazenove, Macquarie, Evolution, Mirabaud nor Renaissance will be responsible to anyone other than the Company for providing the protections afforded to the respective clients of J.P. Morgan Cazenove, Macquarie, Evolution, Mirabaud and Renaissance nor for providing advice in relation to the Placing or any other matter referred to herein.

The distribution of this Announcement and the Placing of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company, J.P. Morgan Cazenove, Macquarie, Evolution, Mirabaud or Renaissance that would permit an offering of such shares or possession or distribution of this Announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company, J.P. Morgan Cazenove, Macquarie, Evolution, Mirabaud and Renaissance to inform themselves about, and to observe, such restrictions.

The information in this press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would require preparation of further prospectuses or other offer documentation, or be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.

No public offer of securities of the Company is being made in Australia, the United Kingdom, the United States, the Republic of South Africa or elsewhere. The information in this press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933 (the "Securities Act"). The securities mentioned herein may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of securities in the United States.

The information in this press release may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIKKADNDBKDBAD
Date   Source Headline
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results
10th Mar 20231:00 pmRNSDirector Appointments & Resignation
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:31 amRNSAppendix 5B
31st Jan 20237:30 amRNSActivities Report for the Quarter Ended 31 Dec 22
19th Jan 20232:15 pmRNSGrant of Options & Performance Rights to Directors
23rd Dec 20228:37 amRNSOutsourcing of the Vele Aluwani Colliery
20th Dec 20223:00 pmRNSExtension of Coal Sales & Marketing Agreement
1st Dec 20229:00 amRNSIDC Loan Update
30th Nov 20224:32 pmRNSResult of AGM
11th Nov 20226:20 pmRNSDirectors' Dealings
4th Nov 20222:06 pmRNSSecond Price Monitoring Extn
4th Nov 20222:00 pmRNSPrice Monitoring Extension
4th Nov 202210:00 amRNSFully Underwritten Rights Issue Offer Closes
31st Oct 20229:31 amRNSAppendix 5B
31st Oct 20229:30 amRNSActivities Report for the Quarter Ended 30 Sep 22
31st Oct 20227:00 amRNSDespatch of Annual Report and Notice of AGM
7th Oct 202211:07 amRNSAnnual General Meeting Details
30th Sep 20229:45 amRNSResults for the Full Year Ended 30 June 2022
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSFully Underwritten A$40M Rights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.